Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective

Clostridioides difficile (C. difficile), known as the major cause of antibiotic-associated diarrhea, is regarded as one of the most common healthcare-associated bacterial infections worldwide. Due to the emergence of hypervirulent strains, development of new therapeutic methods for C. difficile infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Raeisi, Hamideh, Azimirad, Masoumeh, Nabavi-Rad, Ali, Asadzadeh Aghdaei, Hamid, Yadegar, Abbas, Zali, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445313/
https://www.ncbi.nlm.nih.gov/pubmed/36081500
http://dx.doi.org/10.3389/fimmu.2022.972930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445313/
https://www.ncbi.nlm.nih.gov/pubmed/36081500
http://dx.doi.org/10.3389/fimmu.2022.972930

Ejemplares similares